Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 5, Pages 1076-1084
Publisher
Wiley
Online
2015-09-18
DOI
10.1002/ijc.29856
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidental Serous Tubal Intraepithelial Carcinoma and Early Invasive Serous Carcinoma in the Nonprophylactic Setting
- (2015) Jane C. Morrison et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
- (2015) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study
- (2014) Cecilie Madsen et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery
- (2014) Joseph T. Rabban et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
- (2013) Weiva Sieh et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
- (2012) Russell Vang et al. HISTOPATHOLOGY
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis
- (2012) Megan S Rice et al. Journal of Ovarian Research
- Underlying mechanisms of ovarian cancer risk reduction after tubal ligation
- (2011) DAVID CIBULA et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Reclassification of serous ovarian carcinoma by a 2-tier system
- (2011) Diane C. Bodurka et al. CANCER
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study
- (2011) Inger T. Gram et al. INTERNATIONAL JOURNAL OF CANCER
- Tubal origin of ‘ovarian’ low-grade serous carcinoma
- (2011) Jie Li et al. MODERN PATHOLOGY
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
- (2011) W. Glenn McCluggage PATHOLOGY
- Tubal ligation and the risk of ovarian cancer: review and meta-analysis
- (2010) D. Cibula et al. HUMAN REPRODUCTION UPDATE
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma
- (2008) Shannon Salvador et al. GYNECOLOGIC ONCOLOGY
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
- (2008) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started